Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem CellsStem Cell TransplantationGraft vs Host DiseaseTransplantation, AutologousTransplantation ConditioningHematologic NeoplasmsBone MarrowPeripheral Blood Stem Cell TransplantationStem CellsBone Marrow CellsTransplantation ChimeraTissue DonorsWhole-Body IrradiationGraft SurvivalHistocompatibility TestingBusulfanTreatment OutcomeHematopoiesisLeukemiaHistocompatibilityLiver TransplantationCord Blood Stem Cell TransplantationRecurrenceHematopoietic Stem Cell MobilizationMyeloablative AgonistsRetrospective StudiesAntigens, CD34Graft vs Leukemia EffectChimerismCombined Modality TherapyAnemia, AplasticRemission InductionImmunosuppressive AgentsHepatic Veno-Occlusive DiseaseLeukemia, Myeloid, AcuteCell DifferentiationHematologic DiseasesKidney TransplantationHLA AntigensTime FactorsTransplantation, IsogeneicCyclophosphamideMice, Inbred C57BLMyelodysplastic SyndromesTransplantation ImmunologyMultiple MyelomaMesenchymal Stem Cell TransplantationCell TransplantationSurvival RateSurvival AnalysisSevere Combined ImmunodeficiencyGraft vs Tumor EffectCell LineagePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDisease-Free SurvivalLymphocyte TransfusionFlow CytometryMelphalanSiblingsColony-Forming Units AssayVidarabineUnrelated DonorsGraft RejectionLymphocyte DepletionAcute DiseaseGranulocyte Colony-Stimulating FactorStem Cell NicheCytomegalovirus InfectionsT-LymphocytesEmbryonic Stem CellsImmunosuppressionLymphoma, Non-HodgkinAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesAdult Stem CellsAntilymphocyte SerumSalvage TherapyFetal BloodHeart TransplantationLeukemia, MyeloidBone Marrow PurgingCells, CulturedBone and BonesOrgan TransplantationCell SeparationLung TransplantationOpportunistic InfectionsRadiation ChimeraDonor SelectionBone Marrow DiseasesCytarabineImmunocompromised HostPrognosisTransplantationLymphoproliferative DisordersMesenchymal Stromal Cells